Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $111.28 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $73.89 | 4 | $0 (2022) |
| Amgen Inc. | $24.69 | 1 | $0 (2022) |
| ARBOR PHARMACEUTICALS, INC. | $12.70 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $44.03 | 2 | Amgen Inc. ($24.69) |
| 2021 | $67.25 | 4 | AbbVie Inc. ($54.55) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2022 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Inflammation | ||||||
| 02/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2021 | ARBOR PHARMACEUTICALS, INC. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 429 | 457 | $72,271 | $18,461 |
| 2022 | 14 | 1,165 | 1,671 | $83,858 | $26,803 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 339 | 366 | $52,844 | $13,544 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 91 | $19,427 | $4,917 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 165 | $25,792 | $8,881 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 108 | $24,160 | $7,750 | 32.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 164 | 237 | $7,110 | $2,422 | 34.1% |
| 82306 | Vitamin d-3 level | Office | 2022 | 54 | 60 | $5,100 | $1,726 | 33.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 155 | 212 | $4,240 | $1,591 | 37.5% |
| 86480 | Tuberculosis test, gamma interferon | Office | 2022 | 24 | 24 | $4,800 | $1,365 | 28.4% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2022 | 148 | 213 | $3,195 | $1,066 | 33.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 165 | 248 | $3,720 | $714.11 | 19.2% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2022 | 149 | 214 | $2,140 | $558.42 | 26.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 22 | 26 | $1,196 | $205.54 | 17.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 11 | 11 | $440.00 | $181.74 | 41.3% |
| 86225 | Measurement of dna antibody, native or double stranded | Office | 2022 | 11 | 12 | $480.00 | $162.55 | 33.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 20 | 126 | $1,260 | $112.58 | 8.9% |
| 84550 | Uric acid level, blood | Office | 2022 | 14 | 15 | $225.00 | $66.88 | 29.7% |
About Christopher Nicholas
Christopher Nicholas is a Family healthcare provider based in Eagle, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/05/2020. The National Provider Identifier (NPI) number assigned to this provider is 1104427152.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Nicholas has received a total of $111.28 in payments from pharmaceutical and medical device companies, with $44.03 received in 2022. These payments were reported across 6 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($111.28).
As a Medicare-enrolled provider, Nicholas has provided services to 1,594 Medicare beneficiaries, totaling 2,128 services with total Medicare billing of $45,264. Data is available for 2 years (2022–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Eagle, ID
- Active Since 11/05/2020
- Last Updated 01/18/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104427152
Products in Payments
- QULIPTA (Drug) $38.24
- UBRELVY (Drug) $35.65
- Enbrel (Biological) $24.69
- Edarbyclor (Drug) $12.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Eagle
Courtney Flynn, Np, NP
Family — Payments: $2,774
Danielle Sutton, Np, NP
Family — Payments: $2,608
Mrs. Ashley Young, Fnp, FNP
Family — Payments: $1,100
Bethany Mello, Np-C, NP-C
Family — Payments: $1,069
Mrs. Vanessa Bizimana, Np, NP
Family — Payments: $594.73
Alexandria Green, Aprn-Cnp, APRN-CNP
Family — Payments: $578.75